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Background: Previous studies suggest that patients with Chronic Daily Headache (CDH) have higher levels of
anxiety and depressive disorders than patients with episodic migraine or tension-type headache. However, no study
has considered the presence of psychiatric comorbidity in the analysis of personality traits. The aim of this study is
to investigate the prevalence of psychiatric comorbidity and specific personality traits in CDH patients, exploring if
specific personality traits are associated to headache itself or to the psychiatric comorbidity associated with
headache.
Methods: An observational, cross-sectional study. Ninety-four CDH patients with and without medication overuse
were included in the study and assessed by clinical psychiatric interview and Mini International Neuropsychiatric
Interview (M.I.N.I.) as diagnostic tools. Minnesota Multiphasic Personality Inventory-2 (MMPI-2), Hamilton Depression
Rating Scale (HAM-D) were afterwards administered. Patients with and without psychiatric comorbidity were
compared. Further analyses were made by splitting the whole group according to the headache diagnosis and the
presence or not of medication overuse.
Results: Psychiatric comorbidity was detected in 44 patients (46.8%) (group A) and was absent in the remaining 50
patients (53.2%) (group B). Mood and anxiety disorders were the most frequently diagnosed (43.6%).
In the overall group, mean scores of MMPI-2 showed a high level in the so-called neurotic triad; in particular the
mean score in the Hypochondriasis subscale was in the pathologic area (73.55 ± 13.59), while Depression and
Hysteria scores were moderate but not severe (62.53 and 61.61, respectively). In content scales, score in Health
Concern was also high (66.73).
Group A presented higher scores compared to Group B in the following MMPI-2 subscales: Hypochondriasis
(p = .036), Depression (p = .032), Hysteria (p < .0001), Hypomania (p = .030). Group B had a high score only in the
Hypochondriasis subscale. No significant differences were found between chronic migraine (CM)-probable CM
(pCM) plus probable medication overuse headache (pMOH) and chronic tension-type headache (CTTH)-probable
CTTH (pCTTH) plus pMOH patients or between patients with and without drug overuse.
Conclusions: The so-called “Neurotic Profile” reached clinical level only in CDH patients with psychiatric
comorbidity while a high concern about their general health status was a common feature in all CDH patients.
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Chronic daily headache (CDH) is not a universally recog-
nized diagnosis but an umbrella term for a group of head-
ache disorders occurring at least 15 days per month [1-3].
Unfortunately the classification and definition of CDH are
still plagued with difficulties [4]. The CDH population
comprises individuals with chronic tension-type headache
(CTTH) and chronic migraine (CM), both of which may
be associated with medication overuse [5-7]. The majority
of patients reporting CDH have a history of episodic head-
ache, mainly migraine without aura (MWOA), evolving
into a chronic form over the years [8]. CDH is a major
clinical concern and a common health risk, with a preva-
lence of approximately 3% to 5% in the adult population
worldwide [9-11]. Identifying risk factors for progression
has emerged as a major public health priority. Psychiatric
comorbidity has been one of the risk factors most widely
investigated for headache chronification due the signifi-
cant role it may play in this process [12-16] and because it
might be linked to medication overuse in migraineurs
[17]. Many epidemiological and clinical studies have con-
firmed the elevated risk for mood and anxiety disorders in
migraine and in CDH [18-23]. In particular, patients with
CDH showed higher levels of anxiety and depressive dis-
orders than patients with episodic migraine [19]. Some
studies [19,24,25] hypothesized that patients with medica-
tion overuse headache (MOH) may differ psychologically
from other headache patients because of a dependence-
related behavior, but this hypothesis was not confirmed by
more recent findings [26-28].
Personality traits assessed by the Minnesota Multiphasic
Personality Inventory-2 (MMPI-2) [29] disclosed that pa-
tients with CDH showed the so-called “neurotic MMPI-2
profile” characterized by high scores in the first three
scales: Hs (Hypochondriasis), D (Depression), and Hy
(Hysteria) [30,31]. A recent study [27] comparing MMPI
scores in MOH, episodic headache patients and healthy
controls, showed that MOH and episodic headache
patients displayed similar patterns, differentiating only
in Hypochondriasis scale, and that there were no differ-
ences between the three groups in scales measuring
dependence-related behavior. Another recent study [28]
compared MOH sufferers and drug-addicted patients by
means of MMPI-2 dependency scales showing that the
two groups did not share personality characteristics linked
to dependence. The authors argued that rather than a
“true” addiction behavior, a different kind of “dependence”
characterized headache patients related to the need to
avoid pain. No study has hitherto explored if dependence
behaviors in MOH patients are related to the psychiatric
comorbidity often associated with CDH.
Aims of the present study were to: 1) investigate the preva-
lence of psychiatric comorbidity and specific personality traits
in CDH patients, 2) investigate if specific personality traitscharacterize only patients with psychiatric comorbidity or
were associated with the headache type.
Methods
One hundred and five consecutive adult patients referred
to the Headache Centre of the Department of Neuro-
logical Sciences of the University of Bologna and satisfying
inclusion criteria for CDH (≥15 days/months for at least
3 months) with or without medication overuse, were
recruited by expert neurologists (S.C., E.S., G.P.). Head-
ache and drug overuse were classified according to the
original [5] and the revised International Classification of
Headache Disorders-II (ICHD-II) criteria [6]. Exclusion
criteria were: age <18, secondary CDH assessed by clinical
examination, biochemical tests or neuroimaging studies.
The study protocol included a psychiatric evaluation by
means of a clinical assessment set up by expert psychia-
trists (M.C., D.G., A.B.) and of the Mini International
Neuropsychiatric Interview (M.I.N.I.) [32] in order to
identify subjects with psychiatric comorbidity. Moreover
the Hamilton Depression Rating Scale (HAM-D) [33] and
the Minnesota Multiphasic Personality Inventory-2
(MMPI-2) [29,34] questionnaires were administered..
M.I.N.I. [32] is a short structured diagnostic interview
for psychiatric disorders as defined by the Diagnostic
and Statistical Manual of Mental Disorders, 4th edition
(DSM-IV) [35] and by the International Classification of
Diseases, 10th edition (ICD-10) [36]. It generates a posi-
tive diagnosis for the main Axis I DSM-IV disorders:
mood, anxiety, eating and substance-related disorders. It
also explores psychotic symptoms to exclude probable
lifetime or current psychotic disorders.
HAM-D [33] is a depression test measuring the sever-
ity of clinical depression symptoms. It is a 21-item mul-
tiple choice questionnaire assessing depression in four
levels: score under 7: no depression, score from 8 to 17:
mild depression, score from 18 to 24: moderate depres-
sion, score over 25: severe depression.
MMPI-2 [29,34] is a 567 true-false item questionnaire
composed of three validity and ten clinical scales. The ques-
tionnaire also includes content scales (clusters of items
concerning the same psychological dimension and beha-
vioral area) and supplementary scales which evaluate broad
personality traits, generalized emotional distress and beha-
vioral dyscontrol. For each scale, a T-score of 65 was consi-
dered as the level of clinical significance in the 95th percentile.
MMPI-2 questionnaires were selected on the basis of the three
validity scales.
M.I.N.I. and HAM-D were administered by a psych-
iatrist, while MMPI-2 was self-reported.
The institutional review board of the Department of
Neurological Sciences of the University of Bologna ap-
proved the study protocol and all participants gave written
informed consent. The study was performed in accordance
Table 1 Patients’ demographic and headache
characteristics
Gender
Male, n (%) 22 (23.4)
Female, n (%) 72 (76.6)
Age (yrs), mean ± sd (min-max) 48.51 ±14.31 (19-75)
Educational level n (%)
Elementary/secondary school, 50 (53,2)
High or graduate school, n (%) 44 (44.7)
Types of headache at onset n (%)
MWOA 78 (83.0)
MWOA +MWA 8 (8.5)
ETTH 5 (5.3)
CTTH 3 (3.2)
Age of chronification (yrs), mean ± sd 38.10 ±14.95
Duration of chronification (yrs), mean ± sd 10.21 ± 10.63
Type of CDH n (%)
(Revised ICHD-II diagnosis) MOH 72 (76.6)
CTTH 18 (19.2)
CM 4 (4.2)
Type of CDH n (%)
(ICDH-II diagnosis) CM 4 (4,2%)
pCM, pMOH 43 (45,7%)
CTTH 18 (19.2%)
pCTTH, pMOH 29 (30.8%)
CTTH = chronic tension-type headache; ETTH = episodic tension-type headache;
MWA=migraine with aura; MWOA=migraine without aura; MOH=medication
overuse headache, CM= chronic migraine, pCM=probable CM, pCTTH= probable
CTTH, pMOH=probable MOH.
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ation of Helsinki.
Data analysis
Descriptive statistics (means ± SD) were conducted on
the sample features. The sample was divided into two
groups according to M.I.N.I. results: patients with and
without psychiatric comorbidity (Group A and Group B,
respectively). Analysis of skewedness and kurtosis
showed that data had a normal distribution. Further ana-
lyses were made by splitting the whole group according
to the presence or absence of medication overuse, and
according to the headache diagnosis: CM or probable
CM (pCM) plus probable MOH (pMOH) vs CTTH or
probable CTTH (pCTTH) plus pMOH according to the
ICDH-II and MOH, CM and CTTH according to the
ICDH-II revised criteria. Moreover we consider which
preventive therapy patients were assuming.
Chi-squared and Student’s T-test were performed to
compare data between groups. Data were analyzed using
the statistical software SPSS 19.0 (Statistical Package for
Social Science). Significance level was set at p < .05.
Results
Descriptive analysis
Ninety-four out of 105 patients with CDH and consecutively
referred to the Headache Center were recruited. Eleven re-
fused to participate in the study, 94 accepted to partecipate
and signed an informed consent. All partecipating patients
received a psychiatric evaluation by means of a clinical assess-
ment and of the M.I.N.I. [32]. Seven patients withdrew their
consent. To the 87 patients left, the HAM-D [33] and the
MMPI-2 [29,34] questionnaires were administered.
According to the original ICHD-II criteria [5], four sub-
jects (4.2%) had a diagnosis of CM, 18 ( 19.1%) of CTTH,
43 (45.7%) had a diagnosis of pCM plus pMOH, and 29
(30.9%) of pCTTH plus pMOH. According to ICHD-II re-
vised criteria [6], four subjects (4.2%) had a diagnosis of
CM, 18 (19.2%) of CTTH, and 72 (76.6%) of MOH.
Table 1 shows patients’ demographic and headache fea-
tures. Drug overuse was significantly higher in pCM +
pMOH patients compared to pCTTH + pMOH patients
(43 vs 29, χ2 = 11.631; p < .001).
Psychiatric comorbidity
Descriptive analysis of M.I.N.I. showed that 44 patients
(46.8%) presented psychiatric comorbidity (group A),
whereas 50 patients (53.2%) did not present any psychiatric
comorbidity (group B) (Table 2). In particular, within group
A, 20 patients (21.2%) were classified as mood disorder suf-
ferers, 16 patients (17%) had an anxiety disorder, six patients
(6.4%) had anxiety and mood disorder and two patients
(2.1%) had other psychiatric disorders (eating disorders).No significant differences in psychiatric comorbidity fre-
quency were found between CM or pCM plus pMOH and
CTTH or pCTTH plus pMOH patients (p = .219), or be-
tween patients with and without drug overuse (p = .534).
No significant differences were found in the percentage of
Group A and Group B patients assuming antidepressant
or mood stabilizer as preventive therapies (10/44 Group A
and 16/50 Group B, χ2 = 0.596; p = .440).
MMPI-2
Among the 94 patients, only 87 correctly completed the
questionnaire, and 4 questionnaires were excluded be-
cause they did not achieve validity’s level described in
the MMPI-2 manual. Statistical analyses were made in
the 10 clinical scales. In the overall group, mean scores
of MMPI-2 showed a high level in the so-called neurotic
triad. In particular the mean score in the Hypochondria-
sis subscale was in the pathologic area (73.55 ± 13.59),
while Depression and Hysteria scores were moderate but
not severe (62, 53 and 61.61, respectively). Secondary
analyses were made on content and supplementary
Table 2 Psychiatric comorbidity









CM 1 (1.1%) 0 (0%) 0 (0%) 0 (0%) 3 (2.1%) 4 (4.2%)
pCM
plus pMOH
8 (8.5%) 7 (7.4%) 2 (2.1%) 1 (1.1%) 25 (26.6%) 43 (45.7%)
CTTH 4 (4.2%) 1 (1.1%) 3 (3.1%) 0 (0%) 10 (10.6%) 18 (19.1%)
pCTTH
plus pMOH
7 (7.4%) 8 (8.5%) 1 (1.1%) 1 (1.1%) 12 (12.8%) 29 (30.8%)
Total 20 (20.2%) 16 (17.0%) 6 (6.4%) 2 (2.1%) 50 (53.2%) 94 (100%)
CM = Chronic migraine, pCM = probable chronic migraine, pMOH = probable medication overuse headache, CTTH = chronic tension-type headache,
pCTTH = probable chronic tension-type headache (according to the original ICHD-II criteria). Group A = patients with psychiatric comorbidity Group B = patients
without psychiatric comorbidity.
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cern was also high (66.73).
Group A showed significantly higher scores in the follow-
ing MMPI-2 subscales when compared to Group B (Table 3):
Hypochondriasis (p = .031), Depression (p = .008), Hysteria
(p < .0001), Psychopatic Deviate (p = .025), Psychasthenia
(p = .0,19), Schizophrenia p = .017), Hypomania (p = .025).
Group B had a high score only in the Hypochondriasis
subscale (70.38 ± 12.78).
In the content scales, group A had high score in Health
Concern (Group A = 69,24, Group B = 64,29; p > .05).
The two groups did not show any high score in content
scales, but differentiated in: Anxiety (Group A = 61,95,
Group B = 57,40; p = .047), Depression (Group A = 60,76,
Group B = 55,50; p = .025), Family Problems (Group A =
59,29, Group B = 54,40; p = .046); Work Interference
(Group A = 58,56, Group B = 52,67; p = .021).
In the supplementary scales no high scores were found, but
the two groups also differentiated in: Anxiety (Group A=
62,51, Group B= 56,60; p = .026) College Maladjustment
(Group A=64,95, Group B= 59,45; p = .026), Gender Femin-
ine (Group A=50,12, Group B=44,57; p = .009), Post-Table 3 Mean and standard deviation (Mean ± sd) of MMPI-2
Total N = 74
MMPI Hs (Hypochondriasis) 73.55 (13.60)
Clinical Scales D (Depression) 62.53 (12.61)
Hy (Hysteria) 61.61 (13.36)
Pd (Psychopathic Deviate) 53.85 (10.27)
Mf (Masculinity-feminility) 46.99 (9.85)
Pa (Paranoia) 55.49 (10.82)
Pt (Psychasthenia) 57.47 (10.78)
Sc (Schizophrenia) 55.75 (10.11)
Ma (Hypomania) 46.62 (11.36)
Si (Social introversion) 57.79 (10.94)
*T-scores > 65 (considered to be the level of clinical significance) are in bold. Group
psychiatric comorbidity. Hyp + Dep + Hys = ”Neurotic profile”. * p < .05.Traumatic Stress disorder (Group A= 60,14, Group B=
54,88; p = .022); Addiction Potential Scale (Group A= 49.02,
Group B= 43,38; p = .008).
No significant differences were found between CM or pCM
plus pMOH and CTTH or pCTTH plus pMOH patients or
between patients with and without drug overuse (Table 4).
HAM-D
We analyzed 87 valid questionnaires. The mean value of the
total sample at Hamilton Depression Scale was 6.4 and it
remained in the normative range indicative for absence of
depression. Group A (n = 43) had a scale mean value indica-
tive for the presence of mild depression (9.47 ± 4.26), signifi-
cantly higher than group B (n = 42; 3.48 ± 3.24) (t = 7.37,
p < .0001). No significant differences were found between CM
or pCM plus pMOH and CTTH or pCTTH plus pMOH pa-
tients (p = .345) or between patients with and without drug
overuse (p= .994).
Discussion
Our study evaluated the prevalence of psychiatric
comorbidity and specific personality traits in CDHscores*
Group A N = 39 Group B N = 35 P
76.80 (13.79) 70.38 (12.78) *0.03
66.19 (12.49) 58,95 (11.81) *0.00
66.78 (12.93) 56.57 (11.87) *0.00
56.39 (9,08) 51.38 (10.85) *0.02
47.76 (8.48) 46.23 (11.09) *0.49
56.63 (9.56) 54.38 (11.93) *0.35
60.27 (10.61) 56.74 (10.34) *0.02
58.41 (9.98) 53.14 (9.65) *0.02
49.44 (10.87) 43.88 (11.29) *0.02
59.90 (10.56) 55.74 (11.03) *0.08
A = patients with psychiatric comorbidity; Group B = patients without
Table 4 Mean and standard deviation (Mean ± sd) of MMPI-2 scores in CM-pCM + pMOH versus CTTH-p CTTH + pMOH
and MOH versus NO MOH
CM and pCM+ pMOH CTTH and pCTTH + pMOH p MOH NO MOH p
N = 42 N = 45 N = 66 N = 21
Hs (Hypochondriasis) 75.21 (11.66) 71.35 (14.82) 0.17 73.96 (13.07) 70.85 (14.64) 0.39
D (Depression) 63.90 (9.88) 60.37 (14.56) 0.18 63.57 (11.48) 57.38 (14.88) 0.09
Hy (Hysteria) 62.85 (10.28) 59.66 (15.39) 0.26 62.22 (12.97) 58.00 (13.70) 0.22
Pd (Psychopathic Deviate) 54.90 (9.82) 52.11 (9.82) 0.22 54.36 (9.82) 50.61 (12.26) 0.21
Mf (Masculinity-feminility) 47.90 (9.69) 47.04 (10.31) 0.69 47.68 (9.52) 46.76 (11.48) 0.74
Pa (Paranoia) 56.69 (9.93) 54.40 (12.12) 0.34 56.53 (10.35) 52.28 (12.97) 0.18
Pt (Psychasthenia) 58.02 (10.63) 56.13 (10.92) 0.42 57.04 (10.68) 57.04 (11.25) 0.99
Sc (Schizophrenia) 55.38 (10.05) 55.53 (10.36) 0.94 55.72 (10.15) 54.61 (10.35) 0.67
Ma (Hypomania) 47.92 (10.20) 45.60 (12.12) 0.33 46.75 (10.60) 46.61 (13.33) 0.96
Si (Social introversion) 57.76 (10.20) 57.51 (11.34) 0.91 58.22 (9.67) 55.76 (13.70) 0.45
T-scores > 65 (considered to be the level of clinical significance) are in bold. CM = Chronic migraine, pCM = probable chronic migraine, pMOH = probable
medication overuse headache, CTTH = chronic tension-type headache, pCTTH = probable chronic tension-type headache (according to the original ICHD-II criteria).
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using both the original [5] and the revised International
Classification of Headache Disorders-II (ICHD-II) [6] cri-
teria to clearly differentiate the type of prevalent headache
(migraine vs tension-type headache) and the presence of
drug overuse.
In our sample drug overuse is significantly increased
in pCM + pMOH patients with respect to pCTTH +
pMOH patients, probably due to the pain severity of
their attacks.
Of the 94 subjects included in the sample, 46.8%
showed psychiatric comorbidity. The disorders most fre-
quently diagnosed were mood and anxiety disorders
(43.6%). These data are in line with some previous litera-
ture [26,37-39], indicating that the most common psy-
chiatric conditions related to migraine were depression,
bipolar disorders, anxiety [19] and somatoform disor-
ders. However, the relationship between CDH and psy-
chiatric disorders is still matter of debate in the
literature, this being also due to the different headache
diagnostic criteria and the different methods adopted in
most of the studies to assess psychiatric disorders
[12-16]. Verri and colleagues [21] found an association
between CDH and at least one psychiatric disorder in
90% of their patients. Juang and colleagues [22] found
that the frequency of any type of anxiety disorder was
significantly higher in patients with CM than in those
with CTTH. This was not confirmed in our sample in
which no differences were found in psychiatric comor-
bidity between the migraine and the tension-type head-
ache groups, and between patients with and without
drug overuse. These findings are in agreement with the
results obtained by Atasoy and colleagues [40] who ana-
lyzed psychiatric comorbidity in 89 MOH patients and
did not find any difference in MOH patients with pre-existing episodic tension-type headache (ETTH) with re-
spect to those with pre-existing MWOA.
Psychiatric comorbidity has often been clinically
discussed rather than systematically studied. The use of
M.I.N.I., a structured clinical psychiatric interview [41],
helped us to establish a diagnosis on reliable and valid
diagnostic criteria. Although M.I.N.I. is considered a
somewhat overinclusive instrument in ‘making diagnosis’
[42], it indicated the presence of depression in our sam-
ple, while HAM-D results revealed that the mood dis-
order was milder than expected. Moreover, after clinical
interviews, psychiatrists reported that psychiatric disor-
ders in MOH appear in subthreshold forms rather than
as full-blown disorders. Even if the percentage of pa-
tients assuming prophylactic therapies with antidepres-
sant or mood stabilizer drugs was similar in both
groups, with and without psychiatric comorbidity, we
can not exclude a role of these drugs in the final results.
Previous MMPI-2 results stressed the presence of the
“neurotic MMPI-2 profile” in headache patients, a pro-
file characterized by a high level of depression, hypo-
chondria and hysteria [27,30,31]. We found that in our
sample, the neurotic triad was detected only in patients
with psychiatric comorbidity, while patients without
psychiatric comorbidity displayed a high score only in
the Hypochondriasis subscale, indicating high concern
for their health status. The presence of the “neurotic
MMPI-2 profile” in chronic headache has already been
the focus of previous studies [27,28] arguing that these
personality traits appeared to be a reaction to chronic
pain rather than a specific feature of headache patients
[43]. Our results suggest for the first time that the “neur-
otic MMPI-2 profile” was not associated to headache per
se, but was a dominant feature in headache patients who
showed comorbidity with psychiatric disorders. However
Rausa et al. The Journal of Headache and Pain 2013, 14:22 Page 6 of 7
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to reveal any casual relationship.
The two groups also differentiated for scores in Addi-
ction Potential Scale: patients with psychiatric comorbidity
had higher scores than patients without, even if the scores
fell in the normal range. Furthermore, the presence of
medication overuse was not a discriminating factor. These
data support Galli et al.’s [28] hypothesis that medication
overuse in CDH patients might not be related to depen-
dence, but rather might be a consequence of chronic pain.
From this perspective, medication overuse could be seen
as the only way patients know to cope with their pain and
maintain a normal lifestyle. However, this hypothesis con-
flicts with other studies on dependence in patients with
MOH [25]. Specific instruments are needed to assess de-
pendence behavior in MOH patients as it seems to have
different theoretical constructs from classic dependence
behavior [27].
A high score in MMPI-2 Health Concern subscale was
found in all CDH patients suggesting concern for their
general health condition, and not only for their head-
ache. This result is concordant with the elevated score
also found in the Hypochondria clinical scale.
We acknowledge the limitations of the present study, the
principal one being that it was performed in a tertiary care
headache clinic so that the investigated sample may not
represent the whole spectrum of CDH patients in the ge-
neral population. Another limitation was that MMPI-2 was
properly completed only by 83 of the 94 subjects included.
Another major problem was the diagnostic distinction of
CDH and drug overuse that remains controversial and
could introduce a selection bias. We tried however to over-
come this limitation, which is intrinsic to all studies investi-
gating headache chronification, by applying the IHS revised
criteria for headache diagnosis.
Conclusion
Our study showed that the so-called Neurotic Profile
(high level of hypochondria, depression and hysteria)
reached a clinical level only in patients with psychiatric
comorbidity and that all CDH patients, independently
from psychiatric comorbidity, had a high score in hypo-
chondria evaluation suggesting a high concern for their
general health status. Large population-based studies are
needed to confirm this original finding and future pro-
spective studies might also evaluate how hypocondria is
a risk factor for transformation from episodic to chronic
headache and if it is possible to modify this aspect by ap-
plying cognitive behavioral interventions.
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